[1] APUA's mission is to strengthen society's defenses against infectious disease by promoting appropriate access and use to antimicrobial agents (antibiotics, antivirals, antimalarials etc.)
APUA has a network of affiliated chapters in over 50 countries, and conducts applied antimicrobial resistance research, education, capacity building and advocacy at the global and grassroots levels.
Wide-scale misuse of antibiotics and other antimicrobials and related resistance to these drugs is challenging infectious disease treatment and health care budgets worldwide.
Following Stuart Levy's retirement in 2018, APUA merged with the International Society of Antimicrobial Chemotherapy (ISAC), effective from February 2019.
Each year, APUA presents its Leadership Award in recognition of outstanding global contributions and commitment to preserve the power of antibiotics.